Radiofrequency ablation for Barrett's esophagus-related neoplasia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F18%3AA1901VYK" target="_blank" >RIV/61988987:17110/18:A1901VYK - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/18:10381814 RIV/00023001:_____/18:00077429
Result on the web
<a href="http://dx.doi.org/10.23736/S0026-4733.18.07783-0" target="_blank" >http://dx.doi.org/10.23736/S0026-4733.18.07783-0</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.23736/S0026-4733.18.07783-0" target="_blank" >10.23736/S0026-4733.18.07783-0</a>
Alternative languages
Result language
angličtina
Original language name
Radiofrequency ablation for Barrett's esophagus-related neoplasia
Original language description
Barrett's esophagus (BE) is a premalignant condition associated with increased risk of developing esophageal adenocarcinoma. In the past, BE patients with high-grade intraepithelial neoplasia (IEN) or early adenocarcinoma (EAC) were indicated for esophagectomy. With the recent advance in endoscopy, endoscopic techniques have surpassed esophagectomy in the treatment of Barrett's esophagus-related neoplasia and minimized the treatment-related morbidity. Patients with IEN are candidates for endoscopic treatment - endoscopic mucosal resection (ER) of visible lesions and/or ablation therapy of flat Barrett's mucosa. ER combined with radiofrequency ablation (RFA) is now considered as a gold standard for treatment of patients with early Barrett's cancer. RFA is currently the most effective method of ablation used in the treatment of low-grade intraepithelial neoplasia/high-grade intraepithelial neoplasia without visible lesions and for ablation of residual Barrett's mucosa following ER/ESD of EAC or HGIN aiming to achieve complete eradication of Barrett's surface and thus, decreasing the risk of recurrent dysplasia or cancer. The rates of complete remission of neoplasia and metaplasia after completion of endoscopic treatment are 81-92.6% and 75-88.2%, respectively. The aim of this article is to review the principles, techniques, indications, efficacy and safety of this ablative method and surveillance of patients after successful treatment with RFA.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30212 - Surgery
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
MINERVA CHIRURGICA
ISSN
0026-4733
e-ISSN
0026-4733
Volume of the periodical
73
Issue of the periodical within the volume
4
Country of publishing house
IT - ITALY
Number of pages
12
Pages from-to
366-377
UT code for WoS article
000445223700003
EID of the result in the Scopus database
2-s2.0-85051142594